Medical News

RSS

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.

26 Aug 2009

Japanese health care: Lower costs and nearly no bankruptcy

The New York Times, in a series of ongoing stories about health care delivery in other countries, interviewed John Creighton Campbell, of the University of Michigan and visiting researcher at the Tokyo University Institute of Gerontology who has studied Japan's health care system.

26 Aug 2009

New president elected for the Foundation for Informed Medical Decision Making non-profit organization

Michael J. Barry, MD, of Massachusetts General Hospital and Harvard Medical School, has been named the new president of the Foundation for Informed Medical Decision Making, the non-profit organization in Boston that has pioneered the creation and use of high quality audio-visual decision aids to enhance patient involvement in their own medical decisions.

26 Aug 2009

Cardiac Science Corporation installs 195 Powerheart AED G3 devices in Atlanta Public School

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced the expansion of the largest AED deployment of any school system in Georgia with 195 Powerheart AED G3 devices from Cardiac Science.

26 Aug 2009

Herbalscience research throws light on causes of allergic rhinitis

Most people might think of nettle as simply a common and aggressive weed that can sting and cause skin irritation. But nettle has also been used for hundreds of years to treat seasonal allergies and other inflammatory diseases, although the precise nature of its anti-inflammatory effect was unknown. Now, scientists with HerbalScience have identified specific bioactives in nettle leaf extracts that inhibit in vitro receptors and enzymes known to be key in generating symptoms of allergic rhinitis, or hay fever.

26 Aug 2009

LaSalle Solutions awards mobility solution and services contract to InfoLogix

InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that it has won a $2.6 million contract with LaSalle Solutions, Inc. to provide a major customer with a wide-ranging mobility solution and services encompassing 3,000 mobile users.

26 Aug 2009

Oxygen Biotherapeutics to present at the Rodman & Renshaw Annual Global Investment Conference

Oxygen Biotherapeutics, Inc. today announced that the company will present at investor conferences in New York on Sept. 9 and Zurich on Sept. 10, 2009.

26 Aug 2009

Versa Card enters into a Medical Services Agreement with Northshore Orthopedics

Versa Card, Inc., doing business as "Spine Pain Management, Inc." (the "Company"), has entered into a Medical Services Agreement with Northshore Orthopedics, Assoc. ("NSO") to open its first spine injury treatment center in Houston, Texas.

26 Aug 2009

New over-the-counter eye drop provides relief to seven symptoms of eye irritation

New entries in the eye care category are changing the way people can take care of their eyes.

26 Aug 2009

Optimum Lightpath chosen as telecommunications provider by Medical Arts Radiology

Optimum Lightpath(SM), a market leader in Ethernet-based communication solutions for New York metropolitan area businesses, today announced that Medical Arts Radiology, one of the largest medical imaging groups in Long Island, has selected Optimum Lightpath as its telecommunications provider.

26 Aug 2009

Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S.

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.

26 Aug 2009

Boehringer Ingelheim selects MicroStrategy software to improve sales reporting and efficiency

MicroStrategy((R)) Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Boehringer Ingelheim (Schweiz) GmbH (named here as Boehringer Switzerland) has selected MicroStrategy to improve its sales reporting and efficiency. Boehringer Switzerland is the Swiss branch of the international pharmaceuticals company Boehringer Ingelheim.

26 Aug 2009

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.

26 Aug 2009

State of Kansas outsources its COBRA administration program

Like many innovative enterprises, the state of Kansas constantly searches for new ways to operate cost-effectively and use tax dollars wisely. One way it does so is by outsourcing its COBRA administration program. And effective October 2009, Kansas City-based COBRAGuard, Inc. will serve as the state's new COBRA administration partner.

26 Aug 2009

Consumer Reports covers issues pertaining to the efficacy and safety of prescription and non-prescription drugs

Consumer Reports and ConsumerReportsHealth.org cover issues pertaining to the efficacy and safety of prescription and non-prescription drugs (including natural medicines), mental health, diet and nutrition, food safety, and fitness.

26 Aug 2009

Nuvilex launches web site for marketing Last Shot Hangover Remedy

Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today the launch of its Last Shot Hangover Remedy(TM) ("Last Shot") web site at www.mylastshot.com. The newly released web site offers Nuvilex' customers product and use information, user testimonials, lists upcoming events, and fan page links to Facebook, Twitter, and YouTube social networking sites.

26 Aug 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.

26 Aug 2009

The American Brain Tumor Association to pursue increased funding of brain tumor research in Senator Kennedy's memory

The following is a statement by Elizabeth Wilson, Executive Director, American Brain Tumor Association on the death of U.S. Senator Edward M. Kennedy: "Senator Kennedy's brain tumor diagnosis just over a year ago brought international attention to this dreadful and devastating disease. He will be remembered as a tireless health care advocate who displayed courage and strength in his final battle against an unrelenting illness.

26 Aug 2009

New interactive web site launched by DATATRAK

DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the launch of the Company's new web site. Unveiled at the Annual Shareholder Meeting, the interactive web site is a continuation of DATATRAK's singular vision for product and service delivery - DATATRAK ONE(TM).

26 Aug 2009

Endo Pharmaceuticals Solutions announces the beginning of cash tender offer

Endo Pharmaceuticals announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.

26 Aug 2009

Medical News

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Japanese health care: Lower costs and nearly no bankruptcy

New president elected for the Foundation for Informed Medical Decision Making non-profit organization

Cardiac Science Corporation installs 195 Powerheart AED G3 devices in Atlanta Public School

Herbalscience research throws light on causes of allergic rhinitis

LaSalle Solutions awards mobility solution and services contract to InfoLogix

Oxygen Biotherapeutics to present at the Rodman & Renshaw Annual Global Investment Conference

Versa Card enters into a Medical Services Agreement with Northshore Orthopedics

New over-the-counter eye drop provides relief to seven symptoms of eye irritation

Optimum Lightpath chosen as telecommunications provider by Medical Arts Radiology

Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S.

Boehringer Ingelheim selects MicroStrategy software to improve sales reporting and efficiency

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

State of Kansas outsources its COBRA administration program

Consumer Reports covers issues pertaining to the efficacy and safety of prescription and non-prescription drugs

Nuvilex launches web site for marketing Last Shot Hangover Remedy

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

The American Brain Tumor Association to pursue increased funding of brain tumor research in Senator Kennedy's memory

New interactive web site launched by DATATRAK

Endo Pharmaceuticals Solutions announces the beginning of cash tender offer

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News